v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (17,465) $ (22,017)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 2,703 1,795
Loss on write-off and disposal of property and equipment 0 16
Gain on lease termination 0 (65)
Stock-based compensation 7,494 8,498
Deferred taxes (360) 0
Reduction of revenue related to stock warrant issued to customer 1,101 397
Amortization of right-of-use asset 820 1,245
Accretion on short-term investments (454) (822)
Change in fair value of warrant liabilities 0 (112)
(Recovery) provision for inventory write-down (488) 261
Recovery of doubtful accounts 0 (16)
Realized gain on sale of available for sale securities (9) 0
Changes in operating assets and liabilities, net of effects of business acquisition:    
Accounts receivable 6,472 4,137
Inventory (3,665) 1,051
Prepaid expenses and other assets (153) (3,883)
Accounts payable (3,536) 4,120
Accrued and other liabilities 134 8,691
Contract liabilities 1,020 (6,515)
Operating lease liability (895) (1,660)
Net cash used in operating activities (7,281) (4,879)
CASH FLOWS FROM INVESTING ACTIVITIES    
Purchases of property and equipment (2,561) (552)
Purchase of short-term investments (10,802) (13,858)
Proceeds from sales and maturities of short-term investments 57,919 27,000
Acquisition of Stereolabs, net of cash acquired (27,493) 0
Net cash provided by investing activities 17,063 12,590
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from exercise of stock options 94 28
Payments received to fund employees tax obligation for vested RSUs 611 632
Net cash provided by financing activities 705 660
Effect of exchange rates on cash and cash equivalents 0 80
Net increase in cash, cash equivalents and restricted cash 10,487 8,451
Cash, cash equivalents and restricted cash at beginning of period 69,980 48,099
Cash, cash equivalents and restricted cash at end of period 80,467 56,550
SUPPLEMENTAL DISCLOSURES OF OPERATING ACTIVITIES:    
Income tax refunds, net of payments (2,118) 56
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING INFORMATION:    
Property and equipment purchases included in accounts payable and accrued liabilities 333 129
Right-of-use assets obtained in exchange for operating lease liability 0 440
Common stock shares issued in the acquisition of Stereolabs $ 22,780 $ 0